Home » Topics » Disease categories and therapies » Endocrine/metabolic

Endocrine/metabolic
RSS

Novavax completes phase Ia trial of generic human testosterone drug

April 21, 1997

Antidiabetic coumarin derivatives from Otsuka

April 21, 1997

Alteon reports positive results from phase II trials with pimagedine

April 18, 1997

Atorvastatin available in Germany for hyperlipidemia

April 18, 1997

Positive phase I data reported for liposomal PGE1 product for erectile dysfunction

April 18, 1997

Inhibitors of ICE and ICE-like proteins claimed by SmithKline Beecham

April 18, 1997

Genome Therapeutics and Creighton University pursue genes associated with osteoporosis

April 17, 1997

American Home Products develops agents for diabetes and diabetic complications

April 17, 1997

Novel bisphosphonates revealed by Yissum

April 17, 1997

Topical herbal cream evaluated for premature ejaculation

April 17, 1997

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for May 22, 2026.
Sangamo presents primate data for prion suppressor ST-506
BioWorld Science
Sangamo Therapeutics Inc. discussed gene regulation approaches for neurodegenerative diseases when presenting findings on their clinical candidate ST-506 for the...
TREM2 agonists detailed in Pfizer patent
BioWorld Science
Pfizer Inc. has reported new triggering receptor expressed on myeloid cells 2 (TREM2) agonists potentially useful for the treatment of neurodegeneration.
Selection Therapeutics identifies new Kv1.3 blockers
BioWorld Science
Selection Therapeutics GmbH has discovered new potassium voltage-gated channel subfamily A member 3 (KCNA3; Kv1.3) blockers potentially useful for the treatment...
Ignis Therapeutics synthesizes new muscarinic M4 receptor PAMs
BioWorld Science
Ignis Therapeutics (Suzhou) Co. Ltd. has patented new muscarinic M4 receptor positive allosteric modulators (PAMs) potentially useful for the treatment of...